{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:39:32Z","timestamp":1792093172522,"version":"4.4.0"},"reference-count":96,"publisher":"The Endocrine Society","issue":"11","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context:<\/jats:title>\n                  <jats:p>Lipodystrophies are heterogeneous, genetic or acquired disorders characterized by selective loss of body fat and predisposition to insulin resistance. The extent of fat loss determines the severity of associated metabolic complications such as diabetes mellitus, hypertriglyceridemia, and hepatic steatosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Evidence Acquisition and Synthesis:<\/jats:title>\n                  <jats:p>Both original and review articles were found via PubMed search reporting on clinical features and management of various types of lipodystrophies and were integrated with the author's knowledge of the field.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion:<\/jats:title>\n                  <jats:p>The autosomal recessive congenital generalized lipodystrophy and autosomal dominant familial partial lipodystrophy (FPL) are the two most common types of genetic lipodystrophies. Mutations in AGPAT2, BSCL2, CAV1, and PTRF have been reported in congenital generalized lipodystrophy and in LMNA, PPARG, AKT2, and PLIN1 in FPL. CIDEC is the disease gene for autosomal recessive, FPL and LMNA and ZMPSTE24 for autosomal recessive, mandibuloacral dysplasia-associated lipodystrophy. Recently, an autosomal recessive autoinflammatory lipodystrophy syndrome was reported to be due to PSMB8 mutation. Molecular genetic bases of many rare forms of genetic lipodystrophies remain to be elucidated. The most prevalent subtype of acquired lipodystrophy currently occurs with prolonged duration of protease inhibitor-containing, highly-active antiretroviral therapy in HIV-infected patients. The acquired generalized and partial lipodystrophies are mainly autoimmune in origin and display complement abnormalities. Localized lipodystrophies occur due to drug or vaccine injections, pressure, panniculitis, and other unknown reasons. The current management includes cosmetic surgery and early identification and treatment of metabolic and other complications with diet, exercise, hypoglycemic drugs, and lipid-lowering agents.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/jc.2011-1159","type":"journal-article","created":{"date-parts":[[2011,8,25]],"date-time":"2011-08-25T03:34:08Z","timestamp":1314243248000},"page":"3313-3325","source":"Crossref","is-referenced-by-count":488,"title":["Lipodystrophies: Genetic and Acquired Body Fat Disorders"],"prefix":"10.1210","volume":"96","author":[{"given":"Abhimanyu","family":"Garg","sequence":"first","affiliation":[{"name":"Division of Nutrition and Metabolic Diseases, Department of Internal Medicine, Center for Human Nutrition, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390-8537"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2011,11,1]]},"reference":[{"key":"2020111810061796100_B1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0002-9343(99)00414-3","article-title":"Lipodystrophies.","volume":"108","author":"Garg","year":"2000","journal-title":"Am J Med"},{"key":"2020111810061796100_B2","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1056\/NEJMra025261","article-title":"Acquired and inherited lipodystrophies.","volume":"350","author":"Garg","year":"2004","journal-title":"N Engl J Med"},{"key":"2020111810061796100_B3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00000441-188507000-00006","article-title":"Singular case of absence of adipose matter in the upper half of the body.","volume":"90","author":"Mitchell","year":"1885","journal-title":"Am J Med Sci"},{"key":"2020111810061796100_B4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/brain\/51.2.147","article-title":"Lipodystrophies: report of seven cases.","volume":"51","author":"Ziegler","year":"1928","journal-title":"Brain"},{"key":"2020111810061796100_B5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1210\/jcem-14-2-193","article-title":"An undiagnosed endocrinometabolic syndrome: report of 2 cases.","volume":"14","author":"Berardinelli","year":"1954","journal-title":"J Clin Endocrinol Metab"},{"key":"2020111810061796100_B6","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors.","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"key":"2020111810061796100_B7","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ecl.2004.03.003","article-title":"Lipodystrophies: rare disorders causing metabolic syndrome.","volume":"33","author":"Garg","year":"2004","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2020111810061796100_B8","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1651-2227.1959.tb17558.x","article-title":"Lipodystrophy and gigantism with associated endocrine manifestations: a new diencephalic syndrome?","volume":"48","author":"Seip","year":"1959","journal-title":"Acta Paediatrica"},{"key":"2020111810061796100_B9","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/jmg.39.10.722","article-title":"Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy.","volume":"39","author":"Van Maldergem","year":"2002","journal-title":"J Med Genet"},{"key":"2020111810061796100_B10","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.1210\/jc.2003-030855","article-title":"Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy.","volume":"88","author":"Agarwal","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020111810061796100_B11","first-page":"503","article-title":"Leptin levels, \u03b2-cell function, and insulin sensitivity in families with congenital and acquired generalized lipoatrophic diabetes.","volume":"83","author":"Pardini","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020111810061796100_B12","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2337\/diabetes.52.6.1573","article-title":"Prevalence of mutations in AGPAT2 among human lipodystrophies.","volume":"52","author":"Magr\u00e9","year":"2003","journal-title":"Diabetes"},{"key":"2020111810061796100_B13","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1210\/jcem.84.9.6103","article-title":"A gene for congenital generalized lipodystrophy maps to human chromosome 9q34.","volume":"84","author":"Garg","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020111810061796100_B14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng880","article-title":"AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34.","volume":"31","author":"Agarwal","year":"2002","journal-title":"Nat Genet"},{"key":"2020111810061796100_B15","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/ng585","article-title":"Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13.","volume":"28","author":"Magr\u00e9","year":"2001","journal-title":"Nat Genet"},{"key":"2020111810061796100_B16","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1210\/jc.2007-1328","article-title":"Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy.","volume":"93","author":"Kim","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2020111810061796100_B17","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1172\/JCI38660","article-title":"Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy.","volume":"119","author":"Hayashi","year":"2009","journal-title":"J Clin Invest"},{"key":"2020111810061796100_B18","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1002\/ajmg.a.33578","article-title":"Congenital generalized lipodystrophy, type 4 (CGL4) associated with myopathy due to novel PTRF mutations.","volume":"152A","author":"Shastry","year":"2010","journal-title":"Am J Med Genet A"},{"key":"2020111810061796100_B19","doi-asserted-by":"crossref","first-page":"e1000874","DOI":"10.1371\/journal.pgen.1000874","article-title":"Fatal cardiac arrhythmia and long-QT syndrome in a new form of congenital generalized lipodystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations.","volume":"6","author":"Rajab","year":"2010","journal-title":"PLoS Genet"},{"key":"2020111810061796100_B20","doi-asserted-by":"crossref","first-page":"E1195","DOI":"10.1152\/ajpendo.90958.2008","article-title":"Biochemistry, physiology, and genetics of GPAT, AGPAT, and lipin enzymes in triglyceride synthesis.","volume":"296","author":"Takeuchi","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020111810061796100_B21","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1194\/jlr.M004762","article-title":"Enzymatic activity of the human 1-acylglycerol-3-phosphate-O-acyltransferase isoform 11: upregulated in breast and cervical cancers.","volume":"51","author":"Agarwal","year":"2010","journal-title":"J Lipid Res"},{"key":"2020111810061796100_B22","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S1043-2760(03)00078-X","article-title":"Congenital generalized lipodystrophy: significance of triglyceride biosynthetic pathways.","volume":"14","author":"Agarwal","year":"2003","journal-title":"Trends Endocrinol Metab"},{"key":"2020111810061796100_B23","doi-asserted-by":"crossref","first-page":"20890","DOI":"10.1073\/pnas.0704154104","article-title":"The lipodystrophy protein seipin is found at endoplasmic reticulum lipid droplet junctions and is important for droplet morphology.","volume":"104","author":"Szymanski","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020111810061796100_B24","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1083\/jcb.200711136","article-title":"Fld1p, a functional homologue of human seipin, regulates the size of lipid droplets in yeast.","volume":"180","author":"Fei","year":"2008","journal-title":"J Cell Biol"},{"key":"2020111810061796100_B25","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.2337\/db08-0184","article-title":"The human lipodystrophy gene BSCL2\/seipin may be essential for normal adipocyte differentiation.","volume":"57","author":"Payne","year":"2008","journal-title":"Diabetes"},{"key":"2020111810061796100_B26","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1210\/jc.2008-0426","article-title":"Caveolin-1: a new locus for human lipodystrophy.","volume":"93","author":"Garg","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2020111810061796100_B27","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1210\/jc.2003-030835","article-title":"Phenotypic heterogeneity in body fat distribution in patients with congenital generalized lipodystrophy due to mutations in the AGPAT2 or Seipin genes.","volume":"88","author":"Simha","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020111810061796100_B28","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1002\/ajmg.a.32457","article-title":"Novel subtype of congenital generalized lipodystrophy associated with muscular weakness and cervical spine instability.","volume":"146A","author":"Simha","year":"2008","journal-title":"Am J Med Genet A"},{"key":"2020111810061796100_B29","first-page":"293","article-title":"New syndrome manifested by mandibular hypoplasia, acroosteolysis, stiff joints and cutaneous atrophy (mandibuloacral dysplasia) in two unrelated boys","volume-title":"The clinical delineation of birth defects: orofacial structures","author":"Sensenbrenner","year":"1971"},{"key":"2020111810061796100_B30","first-page":"291","article-title":"New syndrome manifested by mandibular hypoplasia, acroosteolysis, stiff joints and cutaneous atrophy (mandibuloacral dysplasia) in two unrelated boys.","volume":"7","author":"Young","year":"1971","journal-title":"Birth Defects"},{"key":"2020111810061796100_B31","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1210\/jc.2002-021575","article-title":"Genetic and phenotypic heterogeneity in patients with mandibuloacral dysplasia-associated lipodystrophy.","volume":"88","author":"Simha","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020111810061796100_B32","first-page":"93","article-title":"Severe insulin resistance and diabetes mellitus in mandibuloacral dysplasia.","volume":"146","author":"Freidenberg","year":"1992","journal-title":"Am J Dis Child"},{"key":"2020111810061796100_B33","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1086\/341908","article-title":"Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A\/C.","volume":"71","author":"Novelli","year":"2002","journal-title":"Am J Hum Genet"},{"key":"2020111810061796100_B34","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/hmg\/ddg213","article-title":"Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia.","volume":"12","author":"Agarwal","year":"2003","journal-title":"Hum Mol Genet"},{"key":"2020111810061796100_B35","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2310\/6650.2006.05068","article-title":"Focal segmental glomerulosclerosis in patients with mandibuloacral dysplasia due to zinc metalloproteinase deficiency.","volume":"54","author":"Agarwal","year":"2006","journal-title":"J Investig Med"},{"key":"2020111810061796100_B36","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1002\/ajmg.a.33664","article-title":"Early onset mandibuloacral dysplasia due to compound heterozygous mutations in ZMPSTE24.","volume":"152A","author":"Ahmad","year":"2010","journal-title":"Am J Med Genet A"},{"key":"2020111810061796100_B37","doi-asserted-by":"crossref","first-page":"E58","DOI":"10.1210\/jc.2010-0488","article-title":"An autosomal recessive syndrome of joint contractures, muscular atrophy, microcytic anemia, and panniculitis-associated lipodystrophy.","volume":"95","author":"Garg","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2020111810061796100_B38","first-page":"173","article-title":"[A case of partial lipodystrophy with erythema, dactylic deformities, calcification of the basal ganglia, immunological disorders and low IQ level (author's translation)].","volume":"20","author":"Horikoshi","year":"1980","journal-title":"Rinsho Shinkeigaku"},{"key":"2020111810061796100_B39","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2169\/internalmedicine.32.42","article-title":"Hereditary lipo-muscular atrophy with joint contracture, skin eruptions and hyper-\u03b3-globulinemia: a new syndrome.","volume":"32","author":"Tanaka","year":"1993","journal-title":"Intern Med"},{"key":"2020111810061796100_B40","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.ajhg.2010.10.031","article-title":"PSMB8 encoding the \u03b25i proteasome subunit is mutated in joint contractures, muscle atrophy, microcytic anemia, and panniculitis-induced lipodystrophy syndrome.","volume":"87","author":"Agarwal","year":"2010","journal-title":"Am J Hum Genet"},{"key":"2020111810061796100_B41","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2174\/1389203043379774","article-title":"Proteasome function in antigen presentation: immunoproteasome complexes, peptide production, and interactions with viral proteins.","volume":"5","author":"Rivett","year":"2004","journal-title":"Curr Protein Pept Sci"},{"key":"2020111810061796100_B42","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jaad.2009.04.046","article-title":"Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome.","volume":"62","author":"Torrelo","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"2020111810061796100_B43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525\u20131470.2010.01163.x","article-title":"Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature syndrome: a case report","author":"Ramot","year":"2010","journal-title":"Pediatr Dermatol"},{"key":"2020111810061796100_B44","first-page":"33","article-title":"Familial lipoatrophic diabetes with dominant transmission. A new syndrome.","volume":"43","author":"Dunnigan","year":"1974","journal-title":"Q J Med"},{"key":"2020111810061796100_B45","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/jmg.23.2.120","article-title":"Familial partial lipodystrophy: two types of an X linked dominant syndrome, lethal in the hemizygous state.","volume":"23","author":"K\u00f6bberling","year":"1986","journal-title":"J Med Genet"},{"key":"2020111810061796100_B46","first-page":"170","article-title":"Adipose tissue distribution in patients with familial partial lipodystrophy (Dunnigan variety).","volume":"84","author":"Garg","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020111810061796100_B47","first-page":"1776","article-title":"Gender differences in the prevalence of metabolic complications in familial partial lipodystrophy (Dunnigan variety).","volume":"85","author":"Garg","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020111810061796100_B48","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0002-9343(02)01070-7","article-title":"Multisystem dystrophy syndrome due to novel missense mutations in the amino-terminal head and \u03b1-helical rod domains of the lamin A\/C gene.","volume":"112","author":"Garg","year":"2002","journal-title":"Am J Med"},{"key":"2020111810061796100_B49","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1399-0004.2009.01350.x","article-title":"Overlapping syndrome with familial partial lipodystrophy, Dunnigan variety and cardiomyopathy due to amino-terminal heterozygous missense lamin A\/C mutations.","volume":"78","author":"Subramanyam","year":"2010","journal-title":"Clin Genet"},{"key":"2020111810061796100_B50","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/ng0398-292","article-title":"Localization of the gene for familial partial lipodystrophy (Dunnigan variety) to chromosome 1q21\u201322.","volume":"18","author":"Peters","year":"1998","journal-title":"Nat Genet"},{"key":"2020111810061796100_B51","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/hmg\/9.1.109","article-title":"Nuclear lamin A\/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy.","volume":"9","author":"Cao","year":"2000","journal-title":"Hum Mol Genet"},{"key":"2020111810061796100_B52","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/72807","article-title":"LMNA, encoding lamin A\/C, is mutated in partial lipodystrophy.","volume":"24","author":"Shackleton","year":"2000","journal-title":"Nat Genet"},{"key":"2020111810061796100_B53","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1086\/302836","article-title":"Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A\/C.","volume":"66","author":"Speckman","year":"2000","journal-title":"Am J Hum Genet"},{"key":"2020111810061796100_B54","first-page":"408","article-title":"A novel heterozygous mutation in peroxisome proliferator-activated receptor-\u03b3 gene in a patient with familial partial lipodystrophy.","volume":"87","author":"Agarwal","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020111810061796100_B55","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.2337\/diabetes.51.12.3586","article-title":"PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy.","volume":"51","author":"Hegele","year":"2002","journal-title":"Diabetes"},{"key":"2020111810061796100_B56","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1172\/JCI28003","article-title":"PPAR \u03b3 and human metabolic disease.","volume":"116","author":"Semple","year":"2006","journal-title":"J Clin Invest"},{"key":"2020111810061796100_B57","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1126\/science.1096706","article-title":"A family with severe insulin resistance and diabetes due to a mutation in AKT2.","volume":"304","author":"George","year":"2004","journal-title":"Science"},{"key":"2020111810061796100_B58","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/emmm.200900037","article-title":"Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC.","volume":"1","author":"Rubio-Cabezas","year":"2009","journal-title":"EMBO Mol Med"},{"key":"2020111810061796100_B59","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1056\/NEJMoa1007487","article-title":"Perilipin deficiency and autosomal dominant partial lipodystrophy.","volume":"364","author":"Gandotra","year":"2011","journal-title":"N Engl J Med"},{"key":"2020111810061796100_B60","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/MOL.0b013e32830dd09b","article-title":"Triglyceride containing lipid droplets and lipid droplet-associated proteins.","volume":"19","author":"Olofsson","year":"2008","journal-title":"Curr Opin Lipidol"},{"key":"2020111810061796100_B61","first-page":"315","article-title":"Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis.","volume":"119","author":"Semple","year":"2009","journal-title":"J Clin Invest"},{"key":"2020111810061796100_B62","first-page":"2808","article-title":"FSP27 contributes to efficient energy storage in murine white adipocytes by promoting the formation of unilocular lipid droplets.","volume":"118","author":"Nishino","year":"2008","journal-title":"J Clin Invest"},{"key":"2020111810061796100_B63","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1038\/sj.cdd.4402197","article-title":"Human lipodystrophies linked to mutations in A-type lamins and to HIV protease inhibitor therapy are both associated with prelamin A accumulation, oxidative stress and premature cellular senescence.","volume":"14","author":"Caron","year":"2007","journal-title":"Cell Death Differ"},{"key":"2020111810061796100_B64","first-page":"59","article-title":"Phenotypic heterogeneity in patients with familial partial lipodystrophy (Dunnigan variety) related to the site of mis-sense mutations in lamin A\/C (LMNA) gene.","volume":"86","author":"Garg","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020111810061796100_B65","doi-asserted-by":"crossref","first-page":"5655","DOI":"10.1210\/jc.2004-0280","article-title":"A single-base mutation in the peroxisome proliferator-activated receptor \u03b34 promoter associated with altered in vitro expression and partial lipodystrophy.","volume":"89","author":"Al-Shali","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020111810061796100_B66","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1210\/jc.2009-0472","article-title":"Atypical progeroid syndrome due to heterozygous missense LMNA mutations.","volume":"94","author":"Garg","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2020111810061796100_B67","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1056\/NEJMoa0706898","article-title":"Phenotype and course of Hutchinson-Gilford progeria syndrome.","volume":"358","author":"Merideth","year":"2008","journal-title":"N Engl J Med"},{"key":"2020111810061796100_B68","doi-asserted-by":"crossref","first-page":"E192","DOI":"10.1210\/jc.2010-0419","article-title":"A novel syndrome of mandibular hypoplasia, deafness, and progeroid features associated with lipodystrophy, undescended testes, and male hypogonadism.","volume":"95","author":"Shastry","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2020111810061796100_B69","first-page":"423","article-title":"A low birthweight syndrome? Rieger syndrome.","volume":"11","author":"Sensenbrenner","year":"1975","journal-title":"Birth Defects"},{"key":"2020111810061796100_B70","first-page":"46","article-title":"Rieger anomaly and growth retardation (the S-H-O-R-T syndrome).","volume":"11","author":"Gorlin","year":"1975","journal-title":"Birth Defects"},{"key":"2020111810061796100_B71","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/ajmg.a.31840","article-title":"Body fat distribution and metabolic variables in patients with neonatal progeroid syndrome.","volume":"143A","author":"O'Neill","year":"2007","journal-title":"Am J Med Genet A"},{"key":"2020111810061796100_B72","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.md.0000111061.69212.59","article-title":"Clinical features and metabolic and autoimmune derangements in acquired partial lipodystrophy: report of 35 cases and review of the literature.","volume":"83","author":"Misra","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"2020111810061796100_B73","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00005792-200303000-00007","article-title":"Clinical features and metabolic derangements in acquired generalized lipodystrophy: case reports and review of the literature.","volume":"82","author":"Misra","year":"2003","journal-title":"Medicine"},{"key":"2020111810061796100_B74","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1210\/jc.2002-020794","article-title":"Lipodystrophy in human immunodeficiency virus-infected patients.","volume":"87","author":"Chen","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020111810061796100_B75","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1086\/313854","article-title":"HIV protease inhibitor-related lipodystrophy syndrome.","volume":"30","author":"Carr","year":"2000","journal-title":"Clin Infect Dis"},{"key":"2020111810061796100_B76","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMra041811","article-title":"Cardiovascular risk and body-fat abnormalities in HIV-infected adults.","volume":"352","author":"Grinspoon","year":"2005","journal-title":"N Engl J Med"},{"key":"2020111810061796100_B77","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1210\/jc.2008-1703","article-title":"Complement abnormalities in acquired lipodystrophy revisited.","volume":"94","author":"Savage","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2020111810061796100_B78","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1084\/jem.177.6.1827","article-title":"Complement-mediated adipocyte lysis by nephritic factor sera.","volume":"177","author":"Mathieson","year":"1993","journal-title":"J Exp Med"},{"key":"2020111810061796100_B79","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1086\/505885","article-title":"Sequencing of the reannotated LMNB2 gene reveals novel mutations in patients with acquired partial lipodystrophy.","volume":"79","author":"Hegele","year":"2006","journal-title":"Am J Hum Genet"},{"key":"2020111810061796100_B80","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.bbrc.2008.07.033","article-title":"HIV-protease inhibitors block the enzymatic activity of purified Ste24p.","volume":"374","author":"Hudon","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"2020111810061796100_B81","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0140-6736(02)08094-7","article-title":"Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance.","volume":"359","author":"Bastard","year":"2002","journal-title":"Lancet"},{"key":"2020111810061796100_B82","doi-asserted-by":"crossref","first-page":"20251","DOI":"10.1074\/jbc.C000228200","article-title":"The mechanism of insulin resistance caused by HIV protease inhibitor therapy.","volume":"275","author":"Murata","year":"2000","journal-title":"J Biol Chem"},{"key":"2020111810061796100_B83","doi-asserted-by":"crossref","first-page":"F25","DOI":"10.1097\/00002030-200002180-00001","article-title":"A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome.","volume":"14","author":"Carr","year":"2000","journal-title":"AIDS"},{"key":"2020111810061796100_B84","doi-asserted-by":"crossref","first-page":"14711","DOI":"10.1021\/bi035596s","article-title":"Toxicity of nucleoside analogues used to treat AIDS and the selectivity of the mitochondrial DNA polymerase.","volume":"42","author":"Lee","year":"2003","journal-title":"Biochemistry"},{"key":"2020111810061796100_B85","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1023\/A:1006877012241","article-title":"Mitochondrial DNA mutations in multiple symmetric lipomatosis.","volume":"174","author":"Klopstock","year":"1997","journal-title":"Mol Cell Biochem"},{"key":"2020111810061796100_B86","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1006\/mgme.2000.3092","article-title":"Familial partial lipodystrophy: a monogenic form of the insulin resistance syndrome.","volume":"71","author":"Hegele","year":"2000","journal-title":"Mol Genet Metab"},{"key":"2020111810061796100_B87","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jacc.2008.06.044","article-title":"Long-term outcome and risk stratification in dilated cardiolaminopathies.","volume":"52","author":"Pasotti","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2020111810061796100_B88","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1463-1326.2008.00978.x","article-title":"Prolonged thiazolidinedione therapy does not reverse fat loss in patients with familial partial lipodystrophy, Dunnigan variety.","volume":"10","author":"Simha","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"2020111810061796100_B89","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1210\/jc.2007-2356","article-title":"Fatty acid metabolism in patients with PPAR\u03b3 mutations.","volume":"93","author":"Tan","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2020111810061796100_B90","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMoa012437","article-title":"Leptin-replacement therapy for lipodystrophy.","volume":"346","author":"Oral","year":"2002","journal-title":"N Engl J Med"},{"key":"2020111810061796100_B91","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2337\/diacare.26.1.30","article-title":"Effect of leptin replacement on intrahepatic and intramyocellular lipid content in patients with generalized lipodystrophy.","volume":"26","author":"Simha","year":"2003","journal-title":"Diabetes Care"},{"key":"2020111810061796100_B92","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.metabol.2006.11.010","article-title":"Long-term efficacy of leptin replacement in patients with Dunnigan-type familial partial lipodystrophy.","volume":"56","author":"Park","year":"2007","journal-title":"Metabolism"},{"key":"2020111810061796100_B93","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1210\/jc.2010-0490","article-title":"Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data.","volume":"95","author":"Falutz","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2020111810061796100_B94","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/01.mol.0000217898.52197.18","article-title":"Lipodystrophy: lessons in lipid and energy metabolism.","volume":"17","author":"Simha","year":"2006","journal-title":"Curr Opin Lipidol"},{"key":"2020111810061796100_B95","first-page":"507","article-title":"Lipodystrophies: disorders of adipose tissue biology.","volume":"1791","author":"Garg","year":"2009","journal-title":"Biochem Biophys Acta"},{"key":"2020111810061796100_B96","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev.genom.7.080505.115715","article-title":"Genetic disorders of adipose tissue development, differentiation and death.","volume":"7","author":"Agarwal","year":"2006","journal-title":"Annu Rev Genomics Hum Genet"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/96\/11\/3313\/34383953\/jcem3313.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/96\/11\/3313\/34383953\/jcem3313.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T15:40:09Z","timestamp":1605714009000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/96\/11\/3313\/2834182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,1]]},"references-count":96,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2011-1159","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,1]]}}}